Identification and Characterization of Novel Founder Mutations in NDRG1 : Refining the Genetic Landscape of Charcot-Marie-Tooth Disease Type 4D in Bulgaria.
Derek AtkinsonTeodora ChamovaAyse CandayanKristina KastrevaOgnian AsenovIvan LitvinenkoAlejandro Estrada-CuzcanoEls De VriendtGeorgi KukushevIvailo TournevAlbena JordanovaPublished in: International journal of molecular sciences (2024)
Charcot-Marie-Tooth neuropathy type 4D (CMT4D) is a rare genetic disorder of the peripheral nervous system caused by biallelic mutations in the N-Myc Downstream Regulated 1 gene ( NDRG1 ). Patients present with an early onset demyelinating peripheral neuropathy causing severe distal muscle weakness and sensory loss, leading to loss of ambulation and progressive sensorineural hearing loss. The disorder was initially described in the Roma community due to a common founder mutation, and only a handful of disease-causing variants have been described in this gene so far. Here, we present genetic and clinical findings from a large Bulgarian cohort of demyelinating CMT patients harboring recurrent and novel variants in the NDRG1 gene. Notably, two splice-site variants are exclusive to Bulgarian Muslims and reside in ancestral haplotypes, suggesting a founder effect. Functional characterization of these novel variants implicates a loss-of-function mechanism due to shorter gene products. Our findings contribute to a deeper understanding of the genetic and clinical heterogeneity of CMT4D and highlight novel founder mutations in the ethnic minority of Bulgarian Muslims.
Keyphrases
- copy number
- genome wide
- early onset
- end stage renal disease
- newly diagnosed
- ejection fraction
- dna methylation
- chronic kidney disease
- peritoneal dialysis
- healthcare
- single cell
- mental health
- late onset
- transcription factor
- genome wide identification
- skeletal muscle
- gene expression
- autism spectrum disorder
- patient reported outcomes
- intellectual disability
- genome wide analysis